219 related articles for article (PubMed ID: 32915373)
1. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
3. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
[TBL] [Abstract][Full Text] [Related]
4. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
[TBL] [Abstract][Full Text] [Related]
5. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.
Lin J; Zhao Y; Zhou Y; Tian Y; He Q; Lin J; Hao H; Zou B; Jiang L; Zhao G; Lin W; Xu Y; Li Z; Xue F; Li S; Fu W; Li Y; Xu Z; Li Y; Chen J; Zhou X; Zhu Z; Cai L; Li E; Li H; Zheng C; Li P; Huang C; Xie J
JAMA Netw Open; 2021 Jul; 4(7):e2114180. PubMed ID: 34313744
[TBL] [Abstract][Full Text] [Related]
7. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
Li Y; Bai M; Gao Y
World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
10. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
12. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study.
Zeng X; Zhang P; Zhu G; Li C; Zhang R; Yu M; Lin G; Di M; Jiang C; Li Y; Sun Y; Xia L; Chi P; Tao K
World J Surg Oncol; 2023 Sep; 21(1):300. PubMed ID: 37736728
[TBL] [Abstract][Full Text] [Related]
14. Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
Chou WC; Chang KP; Lu CH; Chen MF; Cheng YF; Yeh KY; Wang CH; Lin YC; Yeh TS
Head Neck; 2017 May; 39(5):860-867. PubMed ID: 28152230
[TBL] [Abstract][Full Text] [Related]
15. External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer.
Kim JH; Kim HS; Seo WY; Nam CM; Kim KY; Jeung HC; Lai JF; Chung HC; Noh SH; Rha SY
Ann Oncol; 2012 Feb; 23(2):361-7. PubMed ID: 21566150
[TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer.
Tonello AS; Capelli G; Bao QR; Marchet A; Farinati F; Pawlik TM; Gregori D; Pucciarelli S; Spolverato G
Updates Surg; 2021 Oct; 73(5):1879-1890. PubMed ID: 34125428
[TBL] [Abstract][Full Text] [Related]
17. Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study.
Xu BB; He XY; Zhou YB; He QL; Tian YT; Hao HK; Qiu XT; Jiang LX; Zhao G; Li Z; Xu YC; Fu WH; Xue FQ; Li SL; Xu ZK; Zhu ZG; Li Y; Li E; Chen JP; Li HL; Cai LS; Wu D; Li P; Zheng CH; Xie JW; Lu J; Huang CM
Int J Surg; 2023 Jun; 109(6):1668-1676. PubMed ID: 37076132
[TBL] [Abstract][Full Text] [Related]
18. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
[TBL] [Abstract][Full Text] [Related]
19. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
